Skip to content

Improving Mental Health and Well-Being Via Awe Walks

Effects of Awe on Mental Health and Well-Being

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03550144
Enrollment
60
Registered
2018-06-08
Start date
2016-12-05
Completion date
2018-05-26
Last updated
2022-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Awe, Compassion

Keywords

Awe, Compassion, Anxiety, Positive emotions, Aging

Brief summary

Awe is a powerful positive emotion that offsets negative emotion and fosters prosocial behavior. This study examined the effects of awe on health and well-being in healthy older adults. Half of the participants took a weekly awe walk while the other half took a weekly walk with no further instructions.

Detailed description

Awe fosters well-being and positive emotions that promote social relationships. Awe shifts attention from ourselves to the outside world and is associated with diminished self-focused attention. We aimed to increase awe in healthy older adults to test whether greater awe experience would lead to gains in other types of positive emotional experience and reductions in negative emotional experience.

Interventions

BEHAVIORALAwe Walk

To examine the effect of weekly awe walks in cognitively healthy older adults.

BEHAVIORALControl Walk

To examine the effect of weekly walks in cognitively healthy older adults.

Sponsors

University of California, Berkeley
CollaboratorOTHER
University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
40 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Stable medical condition for 3 months prior to screening * Reliant informant with frequent contact with participant who is available to provide observations of participant * Fluent in English or Spanish * Age: 40 and above * Able to complete baseline assessments * Education or work history sufficient to exclude mental retardation * Physically acceptable for this study as confirmed by medical history, physical exam, neurological exam and clinical tests

Exclusion criteria

* Major memory concerns/diagnosed memory condition * Korsakoff encephalopathy * Active substance abuse * Brain tumor * Active neoplastic disease (skin tumors other than melanoma are not exclusionary) * Parkinson's disease * Multiple sclerosis (untreated) * Sleep apnea * History of clinically significant stroke * Current evidence or history in the past 2 years of epilepsy, focal brain lesion, cancer, steroid use, or DSM-IV criteria for any major psychiatric disorder including psychosis, major depression, bipolar disorder, alcohol or substance abuse * Blindness, deafness, language difficulties or any other disability which may prevent the participant from participating or cooperating in the protocol

Design outcomes

Primary

MeasureTime frameDescription
Daily awe experience questionnaire8 weeksIncrease in awe experience

Secondary

MeasureTime frameDescription
Daily compassion experience questionnaire8 weeksIncrease in daily compassion experience
Daily negative emotional experience questionnaire8 weeksDecrease in daily negative emotional experience
Generalized Anxiety Disorder- 7 Item Scale8 weeksDecrease in anxiety
Satisfaction With Life Scale8 weeksIncrease in well-being

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026